What is the difference between Mvasi and Avastin?
Mvasi (bevacizumab-awwb) is a biosimilar to Avastin (bevacizumab).
Mvasi is not interchangeable with Avastin. The prescriber must write a prescription specifically for Mvasi.
A biosimilar, according to the FDA, is a biological product that is highly similar to an FDA-approved biological product, known as a reference product (in this case Avastin), and has no clinically meaningful differences in terms of safety and effectiveness.
See Biosimilar and Interchangeable Biologics: More Treatment Choices
Mvasi has the same approved indications as Avastin, with the exception of hepatocellular carcinoma.
| Avastin | Mvasi | |
|---|---|---|
| Generic Name | bevacizumab | bevacizumab-awwb |
| How Supplied |
|
|
| Indications |
|
|
Mvasi was approved in 2017 as the first biosimilar to Avastin. A second Avastin biosimilar called Zirabev (bevacizumab-bvzr) was approved in 2019, and a third called Alymsys (bevacizumab-maly) was approved in 2022.
Related questions
Read next
What are anti-VEGF drugs (VEGF inhibitors)?
Anti-VEGF drugs slow the abnormal growth of blood vessels associated with certain cancers and degenerative eye conditions, such as age-related macular degeneration. Anti-VEGF stands for anti-vascular endothelial growth factor. Continue reading
How long does it take for Keytruda to work?
The time it takes for Keytruda to work can vary based on the type and stage of cancer. Typically, a response to treatment becomes apparent within 2-4 months of starting Keytruda. This timeframe is referred to as "time to response," which measures when a patient's cancer begins to show signs of responding to the treatment. You can find the specific "time to response" data from clinical trials in the table below. Continue reading
What is the success rate of Keytruda?
In general, PD-1 immune checkpoint inhibitors like Keytruda have been shown to significantly prolong overall survival (OS) in some patients with various cancer types, but Keytruda does not always work for everyone. Continue reading
Related medical questions
- What biosimilars have been approved in the United States?
- What are biologic drugs and how do they work?
- What is the difference between Opdivo and Keytruda?
- How effective are Opdivo and Yervoy when taken together?
- Pembrolizumab vs. nivolumab: How do they compare?
- How long does it take for Lenvima to work?
- How long do you take Lenvima?
- How does Nexavar work? Is it a chemo drug?
- How are Inlyta and Keytruda used in kidney cancer?
- What is the success rate of Cabometyx (cabozantinib)?
- How much does Afinitor cost per month?
- How effective is Nexavar? Does it shrink tumors?
- Is Nexavar cost covered by Medicare?
- What type of drug is Lenvima? Is it a chemo drug?
- How long can you take Afinitor for?
- Does Votrient cure cancer or shrink tumors?
- Does Sutent shrink tumors?
- How long do you take Sutent before it starts to work?
- How effective is Lenvima?
- Does Cabometyx (cabozantinib) cure cancer?
- How long does Votrient stay in your system?
- Is Sutent considered a chemotherapy drug?
- Is Votrient a chemotherapy treatment?
- Is Votrient immunotherapy?
- What is the difference between Cabometyx and Cometriq?
- Who makes Bavencio and where is it made?
- What type of drug is Bavencio?
Drug information
Related support groups
- Avastin (10 questions, 46 members)
- Bevacizumab (4 questions, 7 members)
- Mvasi (3 questions, 5 members)
- Renal Cell Carcinoma (31 questions, 102 members)
- Colorectal Cancer (17 questions, 52 members)
- Non-Small Cell Lung Cancer (52 questions, 70 members)
- Cervical Cancer (6 questions, 25 members)
- Glioblastoma Multiforme (1 questions, 26 members)